apparato sciatto verbo human gene therapy clinical development impact factor Palude Equip Freccette
Gene therapy research comes of age: Opportunities and challenges to getting ahead | McKinsey
Gene Therapy | NEJM
Clinical Development of Gene Therapies: The First Three Decades and Counting: Molecular Therapy - Methods & Clinical Development
Gene therapy - Wikipedia
Human Gene Therapy | Mary Ann Liebert, Inc., publishers
Frontiers | CRISPR Gene Therapy: Applications, Limitations, and Implications for the Future | Oncology
The Journal of Gene Medicine - Wiley Online Library
The Landscape of Early Clinical Gene Therapies outside of Oncology: Molecular Therapy
Current Clinical Applications of In Vivo Gene Therapy with AAVs - ScienceDirect
Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: long-term results from a non-randomised, open-label, phase 1/2 trial and expanded access - The Lancet
Frontiers | Gene Therapy Leaves a Vicious Cycle | Oncology
Human Gene Therapy | Mary Ann Liebert, Inc., publishers
Recent trends in gene therapy research and clinical trials. (A)... | Download Scientific Diagram
Estimating the Clinical Pipeline of Cell and Gene Therapies and Their Potential Economic Impact on the US Healthcare System - Value in Health
Human Gene Therapy | Mary Ann Liebert, Inc., publishers
5 Reasons Gene Therapy Companies are Vital to the Future of Biopharma - American Gene Technologies
Estimating the Clinical Pipeline of Cell and Gene Therapies and Their Potential Economic Impact on the US Healthcare System - Value in Health
Gene therapy clinical trials worldwide to 2007—an update - Edelstein - 2007 - The Journal of Gene Medicine - Wiley Online Library
Why commercialization of gene therapy stalled; examining the life cycles of gene therapy technologies | Gene Therapy
Are drug targets with genetic support twice as likely to be approved? Revised estimates of the impact of genetic support for drug mechanisms on the probability of drug approval | PLOS Genetics
Current Landscape of Heart Failure Gene Therapy | Journal of the American Heart Association